Dynacure

Provider of antisense oligonucleotides for the treatment of rare muscular genetic disorder

placeStrasbourg, Grand Est, France calendar_todayFounded 2016 groups29 employees language dynacure.com

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 259 times.

YearFilings
20181
20231
20241

Investor mix

7 investors on record; lead investors include Perceptive Advisors, Andera Partners.

Investor typeCountShare
Venture capital343%
Private equity229%
Bank & private debt114%
Other / undisclosed114%
Coming soon